These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26299777)

  • 1. WITHDRAWN: Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vanderkerchove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD000410. PubMed ID: 26299777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ovulation with gonadotropins in patients with polycystic ovarian syndrome.
    Caruso A; Lanzone A; Fulghesu AM; Guida C; Apa R; Andreani CL; Mancuso S
    Contrib Gynecol Obstet; 1991; 18():42-53. PubMed ID: 1935128
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in induction of ovulation.
    Franks S; Gilling-Smith C
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):136-40. PubMed ID: 8193252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.
    Bordewijk EM; Nahuis M; Costello MF; Van der Veen F; Tso LO; Mol BW; van Wely M
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009090. PubMed ID: 28118681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.
    Filicori M
    Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro fertilization treatment in patients with polycystic ovaries.
    Shulman A; Dor J
    J Assist Reprod Genet; 1997 Jan; 14(1):7-10. PubMed ID: 9013301
    [No Abstract]   [Full Text] [Related]  

  • 9. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 1996 Apr; (1):CD000087. PubMed ID: 17636586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine methods of ovulation induction.
    Balen A
    Baillieres Clin Obstet Gynaecol; 1998 Dec; 12(4):521-39. PubMed ID: 10627765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gonadotropin releasing hormone agonist addition to gonadotropin induction of ovulation in polycystic ovary syndrome patients.
    Schoot DC; Pijlman B; Stijnen T; Fauser BC
    Eur J Obstet Gynecol Reprod Biol; 1992 Jun; 45(1):53-8. PubMed ID: 1535603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of patients with polycystic ovaries undergoing IVF.
    Franks S
    J Assist Reprod Genet; 1997 Jan; 14(1):12-4. PubMed ID: 9013303
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of gonadotropin-releasing hormone agonist for triggering ovulation in high risk gonadotropin stimulating cycles of infertile polycystic ovary syndrome patients].
    Dong H; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):94-6. PubMed ID: 11263206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
    Kol S
    Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
    Venturini PL; Remorgida V; Anserini P; De Cecco L
    Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?
    Palomba S; Orio F; Falbo A; Russo T; Lombardi G; Zullo F
    Hum Reprod; 2004 Nov; 19(11):2682-3; author reply 2683. PubMed ID: 15496601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.